MedPath

Chicago Community Health Study

Not Applicable
Completed
Conditions
Smoking
Interventions
Behavioral: Enhanced Care
Behavioral: TAU
Registration Number
NCT04460417
Lead Sponsor
University of Chicago
Brief Summary

The study examined smokers from the initial COMPASS survey who live in one of three local Census tracks with large concentrations of minority populations and smoking rates, including Washington Park (98.8% African American, 60.5% smoker), Gage Park (76.7% Hispanic, 26.7% smoker), and Bridgeport (34.5% Asian, 27.0% Hispanic, 29.3% smoker), randomizing them to receipt of treatment as usual care advice (via a pamphlet form the National Cancer Institute) versus theoretically-driven and empirically-supported smoking cessation advice session delivered in-person at the UCM.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
204
Inclusion Criteria
  • Currently reside in either the Washington Park, Gage Park, or Bridgeport communities based on current physical address at the time of initial contact for study participation
  • Identify as a current smoker (verified by self-report and exhaled carbon monoxide)
  • Willing and able to sign an informed consent
  • Stable residence and contact information throughout the follow-up period
Exclusion Criteria
  • Not a current smoker
  • Does not live within the pre-determined neighborhood locations
  • Unable to sign informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Enhanced careEnhanced CareParticipants will take part in an approximate one-hour health and smoking feedback session at the University of Chicago in Dr. King's Clinical Addictions Research Laboratory (CARL). The session will follow the Courage to Quitâ„¢ (CTQ) Roadmap program (developed by Dr. King with the Respiratory Health Association). This roadmap shorter version of the larger CTQ program has been specifically designed as an inpatient bedside or outpatient brief intervention guide to assess smoking cessation motivation, consequences of smoking, facts and myths about smoking, barriers to making a change, approved medications, de-bunking myths about medications or treatments without scientific evidence (e-cigarette, laser treatments, herbals, etc.), and gaining social support.
Treatment as UsualTAUParticipants will receive the National Cancer Institute (NCI) pamphlet "Clearing the Air" and access to related online resources, which includes brief advice to quit smoking and medication information.
Primary Outcome Measures
NameTimeMethod
Smoking reductionPast-week CPD at 1- and 6-month follow-up

Change in average cigarettes per day (CPD)

Quit attemptsAny reported (and serious) quit attempts since last session at 1- and 6-month follow-up

Change in number of any and serious (12+hr) quit attempts

Motivation to change smokingIncreases in stage of change at 1- and 6-month follow-ups

Increase in motivation to change smoking behavior via smoking contemplation ladder (Biener-Abrams Contemplation Ladder) scores. Scores are on a 10-point scale from 0-10, with higher scores indicating higher motivation to quit smoking.

Nicotine Replacement Therapy (NRT) useAny reported NRT use since last session at 1- and 6- month follow-up

Change in frequency of NRT use

Nicotine Replacement Therapy (NRT) knowledgeMore accurate knowledge about NRT at 1- and 6-month follow-ups

Increase in accurate knowledge about NRT assessed by two items rated from a 1 (strongly disagree) to 7 (strongly agree) scale measuring agreement to the NRT myths, "NRT causes cancer" and "NRT is only used by weak people".

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Chicago

đŸ‡ºđŸ‡¸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath